Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025)
Prothena Corp Public's (PRTA) quarterly Deferred Taxes came in at $44.9 million in Q2 2025, up 1699.39% year-on-year from $2.5 million in Q2 2024, and up 2786.06% quarter-over-quarter from -$1.7 million in Q1 2025.
Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025) Analysis & Trends
Prothena Corp Public's Deferred Taxes history runs 13 years deep, the most recent figure standing at $44.9 million for Q2 2025.
- On a quarterly basis, Deferred Taxes rose 1699.39% year-over-year to $44.9 million in Q2 2025; TTM through Mar 2026 was $44.9 million, a 645.3% increase from a year earlier, with the FY2025 full-year figure at $43.2 million, up 562.65% from the prior year.
- Deferred Taxes climbed to $44.9 million in Q2 2025 per PRTA's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $44.9 million in Q2 2025 and bottomed at -$4.5 million in Q2 2023.
- The 5-year median for Deferred Taxes is -$2.4 million (2022), against an average of $646888.9.
- Across the five-year window, Deferred Taxes slumped 4088.89% in 2022 and soared 1699.39% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at -$568000.0 in 2021, then tumbled by 468.66% to -$3.2 million in 2022, then retreated by 23.13% to -$4.0 million in 2023, then jumped by 43.75% to -$2.2 million in 2024, then jumped by 2107.64% to $44.9 million in 2025.
- Per Business Quant, the three latest PRTA Deferred Taxes figures stand at $44.9 million (Q2 2025), -$1.7 million (Q1 2025), and -$2.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 44.91 Mn |
| Mar 31, 2025 | -1.67 Mn |
| Dec 31, 2024 | -2.24 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -4.51 Mn |
| Mar 31, 2023 | -3.23 Mn |
| Dec 31, 2022 | -3.23 Mn |
| Sep 30, 2022 | -3.02 Mn |
| Jun 30, 2022 | -2.37 Mn |
| Mar 31, 2022 | -2.52 Mn |
| Dec 31, 2021 | -568,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | 591,000.00 |
| Mar 31, 2021 | 4.62 Mn |
| Dec 31, 2020 | -120,000.00 |
| Sep 30, 2020 | -507,000.00 |